Journal article

Longitudinal Associations Between Smoking Cessation Medications and Alcohol Consumption Among Smokers in the International Tobacco Control Four Country Survey

Sherry A McKee, Kelly C Young-Wolff, Emily LR Harrison, K Michael Cummings, Ron Borland, Christopher W Kahler, Geoffrey T Fong, Andrew Hyland

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH | WILEY | Published : 2013

Abstract

BACKGROUND: Available evidence suggests that quitting smoking does not alter alcohol consumption. However, smoking cessation medications may have a direct impact on alcohol consumption independent of any effects on smoking cessation. Using an international longitudinal epidemiological sample of smokers, we evaluated whether smoking cessation medications altered alcohol consumption independent of quitting smoking. METHODS: Longitudinal data were analyzed from the International Tobacco Control Four Country (ITC-4) Survey between 2007 and 2008, a telephone survey of nationally representative samples of smokers from the United Kingdom, Australia, Canada, and the United States (n = 4,995). Quanti..

View full abstract

Grants

Awarded by NIH


Awarded by U.S. National Cancer Institute


Awarded by Canadian Institutes of Health Research


Awarded by National Health and Medical Research Council of Australia


Awarded by Cancer Research UK


Awarded by NATIONAL CANCER INSTITUTE


Awarded by NATIONAL CENTER FOR RESEARCH RESOURCES


Awarded by NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM


Awarded by NATIONAL INSTITUTE ON DRUG ABUSE


Funding Acknowledgements

This manuscript was supported by NIH grants R01AA015596 (SAM), R01AA017976 (SAM), CTSA-UL1RR024139, and T32AA015496. The ITC Four Country Survey is supported by grants from the U.S. National Cancer Institute (RO1 CA100362) and (P50 CA111236), the Canadian Institutes of Health Research (79551), the National Health and Medical Research Council of Australia (450110), Cancer Research UK (C312/A6465), and the Ontario Institute for Cancer Research (Senior Investigator Award). SAM received an investigator initiated grant from Pfizer in 2009 to study varenicline's interactions with alcohol.